KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice.

Abstract:

BACKGROUND:Epidermal growth factor receptor inhibitor therapy is now approved for treatment of metastatic colorectal carcinomas (CRC) in patients with tumors lacking KRAS mutations. Several procedures to detect KRAS mutations have been developed. However, the analytical sensitivity and specificity of these assays on routine clinical samples are not yet fully characterised. METHODS:The practical aspects and clinical applicability of a KRAS-assay based on Pyrosequencing were evaluated in a series of 314 consecutive CRC cases submitted for diagnostic KRAS analysis. The performance of Pyrosequencing compared to allele-specific, real-time PCR was then explored by a direct comparison of CE-IVD-marked versions of Pyrosequencing and TheraScreen (DxS) KRAS assays for a consecutive subset (n = 100) of the 314 clinical CRC samples. RESULTS:Using Pyrosequencing, 39% of the 314 CRC samples were found KRAS-mutated and several of the mutations (8%) were located in codon 61. To explore the analytical sensitivity of the Pyrosequencing assay, mutated patient DNA was serially diluted with wild-type patient DNA. Dilutions corresponding to 1.25-2.5% tumor cells still revealed detectable mutation signals. In clinical practice, our algorithm for KRAS analysis includes a reanalysis of samples with low tumor cell content (< 10%, n = 56) using an independent assay (allele-specific PCR, DxS). All mutations identified by Pyrosequencing were then confirmed and, in addition, one more mutated sample was identified in this subset of 56 samples. Finally, a direct comparison of the two technologies was done by re-analysis of a subset (n = 100) of the clinical samples using CE-IVD-marked versions of Pyrosequencing and TheraScreen KRAS assays in a single blinded fashion. The number of samples for which the KRAS codon 12/13 mutation status could be defined using the Pyrosequencing or the TheraScreen assay was 94 and 91, respectively, and both assays detected the same number of codon 12 and 13 mutations. CONCLUSIONS:KRAS mutation detection using Pyrosequencing was evaluated on a consecutive set of clinical CRC samples. Pyrosequencing provided sufficient analytical sensitivity and specificity to assess the mutation status in routine formalin-fixed CRC samples, even in tissues with a low tumor cell content.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Sundström M,Edlund K,Lindell M,Glimelius B,Birgisson H,Micke P,Botling J

doi

10.1186/1471-2407-10-660

subject

Has Abstract

pub_date

2010-12-01 00:00:00

pages

660

issn

1471-2407

pii

1471-2407-10-660

journal_volume

10

pub_type

杂志文章
  • Enhancing adherence in trials promoting change in diet and physical activity in individuals with a diagnosis of colorectal adenoma; a systematic review of behavioural intervention approaches.

    abstract:BACKGROUND:Little is known about colorectal adenoma patients' ability to adhere to behavioural interventions promoting a change in diet and physical activity. This review aimed to examine health behaviour intervention programmes promoting change in diet and/or physical activity in adenoma patients and characterise inte...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/s12885-015-1502-8

    authors: McCahon D,Daley AJ,Jones J,Haslop R,Shajpal A,Taylor A,Wilson S,Dowswell G

    更新日期:2015-07-07 00:00:00

  • Disclosure in lesbian, gay and bisexual cancer care: towards a salutogenic healthcare environment.

    abstract:BACKGROUND:The literature on sexual orientation disclosure is arguably one of the most developed in the field of lesbian, gay and bisexual (LGB) people in healthcare in English speaking countries however, relatively little research has been conducted into disclosure in cancer care. Studies have been mainly undertaken i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5895-7

    authors: Fish J,Williamson I,Brown J

    更新日期:2019-07-10 00:00:00

  • Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion.

    abstract:BACKGROUND:Focal adhesion kinase (FAK) and Src are protein tyrosine kinases that physically and functionally interact to facilitate cancer progression by regulating oncogenic processes such as cell motility, survival, proliferation, invasiveness, and angiogenesis. METHOD:To understand how FAK affects oncogenesis throu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-12

    authors: Sachdev S,Bu Y,Gelman IH

    更新日期:2009-01-12 00:00:00

  • Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.

    abstract:BACKGROUND:Cigarette smoking is an established risk factor for bladder cancer. Epidemiological and biological data suggest that genetic polymorphisms in activating and detoxifying enzymes may play a role in determining an individual's susceptibility to bladder cancer in particular when in combination with specific envi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-239

    authors: McGrath M,Michaud D,De Vivo I

    更新日期:2006-10-06 00:00:00

  • The NF-κB p65 and p50 homodimer cooperate with IRF8 to activate iNOS transcription.

    abstract:BACKGROUND:Inducible nitric oxide synthase (iNOS) metabolizes L-arginine to produce nitric oxide (NO) which was originally identified in myeloid cells as a host defense mechanism against pathogens. Recent studies, however, have revealed that iNOS is often induced in tumor cells and myeloid cells in the tumor microenvir...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1808-6

    authors: Simon PS,Sharman SK,Lu C,Yang D,Paschall AV,Tulachan SS,Liu K

    更新日期:2015-10-23 00:00:00

  • A prospective study to assess the value of MMP-9 in improving the appropriateness of urgent referrals for colorectal cancer.

    abstract:BACKGROUND:Bowel cancer is common and is a major cause of death. Most people with bowel symptoms who meet the criteria for urgent referral to secondary care will not be found to have bowel cancer, and some people who are found to have cancer will have been referred routinely rather than urgently. If general practitione...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-251

    authors: Ryan AV,Wilson S,Wakelam MJ,Warmington SA,Dunn JA,Hobbs RF,Martin A,Ismail T

    更新日期:2006-10-23 00:00:00

  • Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

    abstract:BACKGROUND:Locally advanced or metastatic adenocarcinoma of the pancreas remains - despite the implementation of new chemotherapy protocols - a disease with short overall survival (OS). METHODS:Eighty-three patients were treated with locally advanced or metastatic adenocarcinoma of the pancreas with either FOLFIRINOX ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5240-6

    authors: Vogl UM,Andalibi H,Klaus A,Vormittag L,Schima W,Heinrich B,Kafka A,Winkler T,Öhler L

    更新日期:2019-01-08 00:00:00

  • Clinical correlation of opposing molecular signatures in head and neck squamous cell carcinoma.

    abstract:BACKGROUND:The concept of head and neck cancers (HNSCC) having unique molecular signatures is well accepted but relating this to clinical presentation and disease behaviour is essential for patient benefit. Currently the clinical significance of HNSCC molecular subtypes is uncertain therefore personalisation of HNSCC t...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-019-6059-5

    authors: Qadir F,Lalli A,Dar HH,Hwang S,Aldehlawi H,Ma H,Dai H,Waseem A,Teh MT

    更新日期:2019-08-23 00:00:00

  • Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013.

    abstract:BACKGROUND:Tumor testing for mutations in the epidermal growth factor receptor (EGFR) gene is indicated for all newly diagnosed, metastatic lung cancer patients, who may be candidates for first-line treatment with an EGFR tyrosine kinase inhibitor. Few studies have analyzed population-level testing. METHODS:We identif...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4190-3

    authors: Lynch JA,Berse B,Rabb M,Mosquin P,Chew R,West SL,Coomer N,Becker D,Kautter J

    更新日期:2018-03-20 00:00:00

  • Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.

    abstract:BACKGROUND:It is well known that osteopontin (OPN) plays an important role in tumor progression and that a high OPN expression level in several tumor entities correlates with poor prognosis in cancer patients. However, little is known about the prognostic relevance of the OPN mRNA splice variants. METHODS:We analyzed ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-131

    authors: Hahnel A,Wichmann H,Greither T,Kappler M,Würl P,Kotzsch M,Taubert H,Vordermark D,Bache M

    更新日期:2012-04-02 00:00:00

  • Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study.

    abstract:BACKGROUND:Breast cancer risk, development, and treatment are influenced by genetic variation in certain genes, namely those involved in cell proliferation, tumor suppression, and drug metabolism. In turn, the relevance of the aforementioned genetic variation to cancer depends on the ethnic group in question, highlight...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6490-7

    authors: Al-Eitan LN,Rababa'h DM,Alghamdi MA,Khasawneh RH

    更新日期:2019-12-30 00:00:00

  • In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.

    abstract:BACKGROUND:Aberrant methylation is a frequent event in oral cancer. METHODS:In order to better characterize these alterations, a search for genes downregulated by aberrant methylation in oral squamous cell carcinoma (OSCC) was conducted through the mining of ORESTES dataset. Findings were further validated in OSCC cel...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4077-3

    authors: Pereira CM,de Carvalho AC,da Silva FR,Melendez ME,Lessa RC,Andrade VCC,Kowalski LP,Vettore AL,Carvalho AL

    更新日期:2018-02-17 00:00:00

  • Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).

    abstract::Following publication of the original article [1], the authors reported an error in Figure 2, where the color code of the text boxes is reversed. Figure 2-amended shows the correct color association between the text boxes and the different areas in the map: Navarra, neighbouring communities and other Spanish communiti...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-019-6458-7

    authors: de Sabando AR,Lafuente EU,García-Amigot F,Sánchez AA,Garofalo LM,Moreno S,Ardanaz E,Ramos-Arroyo MA

    更新日期:2019-12-17 00:00:00

  • Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

    abstract:BACKGROUND:The Nijmegen Breakage Syndrome is a chromosomal instability disorder characterized by microcephaly, growth retardation, immunodeficiency, and increased frequency of cancers. Familial studies on relatives of these patients indicated that they also appear to be at increased risk of cancer. METHODS:In a candid...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-181

    authors: Desjardins S,Beauparlant JC,Labrie Y,Ouellette G,Durocher F,INHERIT BRCAs.

    更新日期:2009-06-12 00:00:00

  • Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases.

    abstract:BACKGROUND:Downstream of Ras, the serine/threonine kinase B-raf has been reported to be mutated, among other carcinomas, in a substantial subset of primary melanomas with a preponderance of mutations within the kinase domain including the activating V599E and V599K transitions. METHODS:We here investigated a represent...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-58

    authors: Deichmann M,Thome M,Benner A,Kirschner M,Hassanzadeh J,Kurzen H

    更新日期:2005-06-03 00:00:00

  • Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.

    abstract:BACKGROUND:Some historic breakthroughs have been made in immunotherapy of advanced cancer. However, there is still little research on immunotherapy in prostate cancer. We explored the relationship between immune cell infiltration and prostate cancer recurrence and tried to provide new ideas for the treatment of prostat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6391-9

    authors: Rui X,Shao S,Wang L,Leng J

    更新日期:2019-12-03 00:00:00

  • Smokers' interest in a lung cancer screening programme: a national survey in England.

    abstract:BACKGROUND:Following the recommendation of lung cancer screening in the US, screening committees in several European countries are reviewing the evidence for implementing national programmes. However, inadequate participation from high-risk groups poses a potential barrier to its effectiveness. The present study examin...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4430-6

    authors: Quaife SL,Vrinten C,Ruparel M,Janes SM,Beeken RJ,Waller J,McEwen A

    更新日期:2018-05-02 00:00:00

  • Genetic polymorphisms in the osteopontin promoter increases the risk of distance metastasis and death in Chinese patients with gastric cancer.

    abstract:BACKGROUND:In vitro and in vivo studies have suggested that osteopontin (OPN) is associated with many types of cancers. However, no studies have reported the incidence of OPN polymorphisms and the risk of gastric cancer. The aim of this study was to investigate the association between OPN polymorphisms and gastric canc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-477

    authors: Zhao F,Chen X,Meng T,Hao B,Zhang Z,Zhang G

    更新日期:2012-10-16 00:00:00

  • Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer.

    abstract:BACKGROUND:Suppressors of cytokine signaling (SOCS) are important negative feedback regulators of the JAK/STAT signaling pathway, and have been recently investigated for their role in the development of different cancers. In this study, we examined the expression of SOCS1-7 genes in normal and breast cancer tissue and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-178

    authors: Sasi W,Jiang WG,Sharma A,Mokbel K

    更新日期:2010-04-30 00:00:00

  • miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) is a lethal disease, while the precise underlying molecular mechanisms of HCC pathogenesis remain to be defined. MicroRNA (miRNA), a class of non-coding small RNAs, can post-transcriptionally regulate gene expression. Altered miRNA expression has been reported in HCCs. This stu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2801-4

    authors: Zhu Q,Gong L,Wang J,Tu Q,Yao L,Zhang JR,Han XJ,Zhu SJ,Wang SM,Li YH,Zhang W

    更新日期:2016-10-18 00:00:00

  • HAX-1 overexpression, splicing and cellular localization in tumors.

    abstract:BACKGROUND:HAX-1 has been described as a protein potentially involved in carcinogenesis and especially metastasis. Its involvement in regulation of apoptosis and cell migration along with some data indicating its overexpression in cancer cell lines and tumors suggests that HAX-1 may play a role in neoplastic transforma...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-76

    authors: Trebinska A,Rembiszewska A,Ciosek K,Ptaszynski K,Rowinski S,Kupryjanczyk J,Siedlecki JA,Grzybowska EA

    更新日期:2010-03-02 00:00:00

  • Meta-analysis of quantitative diffusion-weighted MR imaging in the differential diagnosis of breast lesions.

    abstract:BACKGROUND:To determine, in a meta-analysis, the diagnostic performance of quantitative diffusion-weighted (DW) MR imaging in patients with breast lesions. METHODS:English and Chinese studies published prior to June 2009 to assess the diagnostic performance of quantitative DWI in patients with breast lesions were revi...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/1471-2407-10-693

    authors: Chen X,Li WL,Zhang YL,Wu Q,Guo YM,Bai ZL

    更新日期:2010-12-29 00:00:00

  • PPARdelta status and mismatch repair mediated neoplasia in the mouse intestine.

    abstract:BACKGROUND:Therapeutic regulation of PPARdelta activity using selective agonists has been proposed for various disorders. However, the consequences of altered peroxisome proliferator-activated receptor delta (PPARdelta) activity in the context of intestinal tumourigenesis remain somewhat unclear. Contradictory evidence...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-113

    authors: Reed KR,Sansom OJ,Hayes AJ,Gescher AJ,Peters JM,Clarke AR

    更新日期:2006-05-03 00:00:00

  • Expression profile and prognostic role of sex hormone receptors in gastric cancer.

    abstract:BACKGROUND:Increasing interest has been devoted to the expression and possible role of sex hormone receptors in gastric cancer, but most of these findings are controversial. In the present study, the expression profile of sex hormone receptors in gastric cancer and their clinicopathological and prognostic value were de...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-566

    authors: Gan L,He J,Zhang X,Zhang YJ,Yu GZ,Chen Y,Pan J,Wang JJ,Wang X

    更新日期:2012-12-02 00:00:00

  • Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage.

    abstract:BACKGROUND:In Scotland colorectal cancer (CRC) is the third most common cancer and a leading cause of cancer death. Epidemiological studies have reported conflicting associations between statins and CRC risk and there is one published report of the association between statins and CRC survival. METHODS:Analysis was car...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-487

    authors: Lakha F,Theodoratou E,Farrington SM,Tenesa A,Cetnarskyj R,Din FV,Porteous ME,Dunlop MG,Campbell H

    更新日期:2012-10-22 00:00:00

  • The clinical response to vemurafenib in a patient with a rare BRAFV600DK601del mutation-positive melanoma.

    abstract:BACKGROUND:Mutations in the activation segment of the v-raf murine sarcoma viral oncogene homolog B (BRAF) gene are present in approximately 50% of melanomas. The selective BRAF inhibitor vemurafenib has demonstrated significant clinical benefits in patients with melanomas harboring the most common mutations (V600E, V6...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-727

    authors: Trudel S,Odolczyk N,Dremaux J,Toffin J,Regnier A,Sevestre H,Zielenkiewicz P,Arnault JP,Gubler B

    更新日期:2014-09-29 00:00:00

  • A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

    abstract:BACKGROUND:5-fluorouracil, leucovorin, irinotecan and oxaliplatin (FOLFIRINOX) is superior to gemcitabine in patients with metastatic pancreatic cancer who have a good performance status. We investigated this combination as neoadjuvant therapy for locally advanced pancreatic cancer (LAPC). METHODS:In this retrospectiv...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-199

    authors: Hosein PJ,Macintyre J,Kawamura C,Maldonado JC,Ernani V,Loaiza-Bonilla A,Narayanan G,Ribeiro A,Portelance L,Merchan JR,Levi JU,Rocha-Lima CM

    更新日期:2012-05-29 00:00:00

  • Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study).

    abstract:BACKGROUND:Fast-track colonoscopy to detect patients with colorectal cancer based on high-risk symptoms is associated with low sensitivity and specificity. The aim was to derive a predictive score of advanced colonic neoplasia in symptomatic patients in fast-track programs. METHODS:All patients referred for fast-track...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-019-5926-4

    authors: Fernández-Bañares F,Clèries R,Boadas J,Ribes J,Oliva JC,Alsius A,Sanz X,Martínez-Bauer E,Galter S,Pujals M,Pujol M,Del Pozo P,Campo R

    更新日期:2019-07-25 00:00:00

  • Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.

    abstract:BACKGROUND:The aim of this population-based study was to assess independent prognostic factors in ovarian cancer using relative survival (RS) and to investigate changes in RS rates from 1982 to 2005. METHODS:Data on 748 patients with ovarian cancer were provided by the Côte d'Or gynaecologic cancer registry. The RS wa...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-622

    authors: Hamidou Z,Causeret S,Dabakuyo TS,Gentil J,Arnould L,Roignot P,Altwegg T,Poillot ML,Bonnetain F,Arveux P

    更新日期:2010-11-10 00:00:00

  • Could aspirin be a lifesaver for prostate cancer patients in prostate cancer-specific mortality?: an update systematic review and meta-analysis.

    abstract:BACKGROUND:Currently, clinical studies on the prognosis of prostate cancer (PC) taking aspirin were developing, but the precise mechanism of aspirin on tumor cells was still unclear. In addition, the conclusion that aspirin can improve the prognosis of PC patients continues to be controversial. Therefore, we collected ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-019-6415-5

    authors: Zhou J,Xia S,Li T,Liu R

    更新日期:2019-12-05 00:00:00